Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John P Atkinson

Showing results (31-40 of 198) with videos related to

Pageof 20
Sort By:
Vaccine|April 24, 2009
Inhibiting complement activation on cells at the step of C3 cleavageM Kathryn Liszewski, Celia J Fang, John P Atkinson
Molecular Immunology|January 17, 2004
ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complementDirk Spitzer, Jacqueline Unsinger, Monica Bessler, et al.
Cleveland Clinic Journal of Medicine|October 29, 2020
The beneficial and pathogenic roles of complement in COVID-19Alfred H J Kim, Xiaobo Wu, John P Atkinson
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2019
ReplyAlfred H J Kim, Vibeke Strand, John P Atkinson
The Journal of Clinical Investigation|April 26, 2005
Targeted and restricted complement activation on acrosome-reacted spermatozoaRebecca C Riley-Vargas, Susan Lanzendorf, John P Atkinson
Trends in Molecular Medicine|November 8, 2002
Human complement receptor type 1 (CR1) binds to a major malarial adhesinMalgorzata Krych-Goldberg, Joann M Moulds, John P Atkinson
Molecular Immunology|August 1, 2018
Preface to the Special issue for the 27th International complement workshopAndrea J Tenner, John P Atkinson, V Michael Holers
Plos Pathogens|December 30, 2008
Surviving mousepox infection requires the complement systemElizabeth A Moulton, John P Atkinson, R Mark L Buller
European Journal of Immunology|September 29, 2009
CD46-induced human Treg enhance B-cell responsesAnja Fuchs, John P Atkinson, Veronique Fremeaux-Bacchi, et al.
Annals of Blood|February 14, 2025
Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46Xiaobo Wu, M Kathryn Liszewski, Anuja Java, et al.
Pageof 20

Showing results (31-40 of 198) with videos related to

Sort By:
Pageof 20
Vaccine|April 24, 2009
Inhibiting complement activation on cells at the step of C3 cleavageM Kathryn Liszewski, Celia J Fang, John P Atkinson
Molecular Immunology|January 17, 2004
ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complementDirk Spitzer, Jacqueline Unsinger, Monica Bessler, et al.
Cleveland Clinic Journal of Medicine|October 29, 2020
The beneficial and pathogenic roles of complement in COVID-19Alfred H J Kim, Xiaobo Wu, John P Atkinson
Arthritis & Rheumatology (Hoboken, N.J.)|May 11, 2019
ReplyAlfred H J Kim, Vibeke Strand, John P Atkinson
The Journal of Clinical Investigation|April 26, 2005
Targeted and restricted complement activation on acrosome-reacted spermatozoaRebecca C Riley-Vargas, Susan Lanzendorf, John P Atkinson
Trends in Molecular Medicine|November 8, 2002
Human complement receptor type 1 (CR1) binds to a major malarial adhesinMalgorzata Krych-Goldberg, Joann M Moulds, John P Atkinson
Molecular Immunology|August 1, 2018
Preface to the Special issue for the 27th International complement workshopAndrea J Tenner, John P Atkinson, V Michael Holers
Plos Pathogens|December 30, 2008
Surviving mousepox infection requires the complement systemElizabeth A Moulton, John P Atkinson, R Mark L Buller
European Journal of Immunology|September 29, 2009
CD46-induced human Treg enhance B-cell responsesAnja Fuchs, John P Atkinson, Veronique Fremeaux-Bacchi, et al.
Annals of Blood|February 14, 2025
Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46Xiaobo Wu, M Kathryn Liszewski, Anuja Java, et al.
Pageof 20